Oculis Holding (CR5) Drug Pipeline
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Oculis Holding Ag (DE:CR5) have in its pipeline
Oculis Holding DE:CR5 is currently developing the following drugs: Methylprednisolone, Privosegtor, Licaminlimab, Artificial Tear Run-In, Vehicle Of Licaminlimab, Vehicle, Dexamethasone Ophthalmic Suspension, Dexamethasone Ophthalmic Suspension, Vehicle Of Ocs-01, Artificial Tears, Licaminlimab, Vehicle Of Ocs-02, Vehicle, Ocs-01, Ocs-05 +Soc Iv Administration, Ocs-01 - Dexamethasone Cyclodextrin Nanoparticle Ophthalmic Suspension 1.5% Mg/Ml. These drug candidates are in various stages of clinical development as the company works toward FDA approval.